Neurizon Therapeutics LimitedASX: NUZ

HEALEY ALS Trial Regimen I Expands to 240 Participants

May 26, 2026 at 11:41 PM UTC · Issued by Neurizon Therapeutics Limited

Neurizon Therapeutics Limited has released a press release.

View Attachment

Earlier from Neurizon Therapeutics

Ethics Approval Received for NUZ-001 Oral Liquid P1 StudyMay 13

All Neurizon Therapeutics news releases